New Market Report: Multi-therapy Drugs: Opportunities for Generics & Biosimilars
Targeting multiple conditions is likely to increase a drug's potential target audience and result in large financial returns for the developing company. With annual sales counted in billions of dollars, these blockbuster drugs are undoubtedly attractive to companies developing generics and biosimilars.
View full press release